- \n
- \nStrategic partnerships with Theon Sensors, Ondas Holdings and Unusual Machines to gain significant and immediate access to international markets and expanded U.S. defense applications<\/p>\n<\/li>\n
- \nTransformative color MicroLED development order with U.S. Army funded by the Industrial Base Analysis and Sustainment (IBAS) program<\/p>\n<\/li>\n
- \n3Q25 net income of $4.1 million and $0.02 earnings per share<\/p>\n<\/li>\n
- \nSolid balance sheet with $26 million in cash on September 27, 2025. $41 million private placement completed subsequent to quarter end<\/p>\n<\/li>\n
- \nErich Manz started as Chief Financial Officer, effective September 2nd<\/p>\n<\/li>\n<\/ul>\n
WESTBOROUGH, Mass.–(BUSINESS WIRE<\/a>)–
\nKopin Corporation (\u201cKopin\u201d or \u201cthe Company\u201d) (Nasdaq: KOPN), a leading developer and provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays, microdisplays subassemblies and related components for defense, enterprise, industrial, and consumer products, today reported financial results for the third quarter ended September 27, 2025.<\/p>\n\n\u201cDevelopments over the past few months have put Kopin in a position of transformational change,\u201d said Michael Murray, CEO of Kopin. \u201cIn August we disclosed a strategic investment by Theon International Plc, a globally recognized developer and manufacturer of advanced thermal imaging and night vision systems for global defense and thermal imaging markets. We believe this announces Kopin as a global player in microdisplays and application specific optical solutions for defense applications, and drives innovation, expands market reach, and reinforces Kopin\u2019s role in delivering mission-critical optical technologies to allied defense forces worldwide. Defense departments in the U.S., EU and Southeast Asia are increasing their budgets to combat security threats and advancing technologies.\u201d<\/p>\n
\nMr. Murray, continued, \u201cSubsequent to the end of the quarter, we announced a $41 million private placement with an expanded group of strategic investors which include further investment from Theon along with Ondas Holdings and Unusual Machines. This investment further solidifies our belief that we have the right technologies to co-develop with strategic partners to provide application-specific solutions.<\/p>\n
\n\u201cLastly, with cash we have available to us, we can now confidently invest in technology and manufacturing development to grow aggressively both in the United States and international markets.\u201d<\/p>\n
Third Quarter Financial Results<\/b><\/p>\n
\nTotal revenues for the third quarter ended September 27, 2025, were $12.0 million, compared to $13.3 million for the third quarter ended September 27, 2024. Year-over-year product revenues decreased to $10.7 million compared to $10.9 million in the year ago period. The decrease was primarily due to a decrease in revenues from products used in pilot helmets and training and simulation which was partially offset by an increase in sales from products used in thermal weapon sights. Third quarter 2025 funded research and development revenues decreased to $1.2 million primarily due to the timing of completed projects and focus on moves to production.<\/p>\n
\nCost of Product Revenues for the third quarter of 2025 were $8.4 million, or 79% of net product revenues, compared with $8.3 million, or 76% of net product revenues for the third quarter of 2024. The increase in cost of product revenue as a percentage of net product revenues for the three months ended September 27, 2025 as compared to the three months ended September 28, 2024 was due higher costs to manufacture training and simulation products and 3DAOI products which was partially offset by improved efficiency in making products for thermal weapon sights.<\/p>\n
\nResearch and Development expenses (R&D) for the third quarter of 2025 were $2.5 million compared to $2.6 million for the third quarter of 2024. Customer-funded R&D expense declined by $0.5 million in the third quarter of 2025 as compared to the third quarter of 2024, while internal R&D increased $0.4 million year over year. Customer funded R&D slightly declined due to programs previously in development being transitioned into production. Internal R&D increased primarily due to an increase in internally developed technology focused on future process improvements.<\/p>\n
\nSelling, General and Administration expenses (SG&A) were $1.6 million for the third quarter of 2025, compared to $5.2 million for the third quarter of 2024. The decrease for the three months ending September 27, 2025, as compared to the three months ending September 28, 2024, was primarily due to a decrease in accrued legal expenses of approximately $4.0 million partially offset by an increase in non-cash stock-based compensation of $0.2 million.<\/p>\n
\nNet Income Attributed to Kopin Corporation for the third quarter of 2025 was $4.1 million, or $0.02 per share, compared with a net loss of ($3.5) million, or ($0.03) per share, for the Third Quarter of 2024.<\/p>\n
\nAll amounts above are estimates and readers should refer to our Form 10-Q for the quarter ended September 27, 2025, for final disposition as well as important risk factors.<\/p>\n
Earnings Call and Webcast<\/b><\/p>\n
\nKopin Corporation management will host the conference call, followed by a question-and-answer session.<\/p>\n
\nDate: Wednesday, November 12, 2025
\n
Time: 8:30 AM Eastern Time (5:30 AM Pacific Time)
\n
U.S. dial-in number: 800-245-3047
\n
International number: 203-518-9765
\n
Conference ID: KOPIN
\n
Webcast: 3Q25 Webcast Link<\/a><\/p>\n\nThe Company will also provide a link at https:\/\/www.kopin.com\/investors\/<\/a> for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.<\/p>\n
\nA telephonic replay of the conference call will also be available through November 26, 2025.<\/p>\n
\nToll-free replay number: 844-512-2921
\n
International replay number: 412-317-6671
\n
Replay passcode: 11160427<\/p>\nAbout Kopin<\/b><\/p>\n
\nKopin Corporation is a leading developer and provider of innovative display and optical technologies sold as critical components and subassemblies for defense, industrial and consumer products. Kopin\u2019s technology portfolio includes ultra-small MicroLED (\u00b5LED), Active-Matrix Liquid Crystal displays (AMLCD), Liquid Crystal on Silicon (LCOS) displays and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. For more information, please visit Kopin\u2019s website at www.kopin.com<\/a>. Kopin is a trademark of Kopin Corporation.<\/p>\n
Forward-Looking Statements<\/b><\/p>\n
\nStatements in this press release may be considered \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), and Section 21E of the Securities Exchange Act of 1934, as amended (the \u201cExchange Act\u201d), which are subject to the safe harbor created by such sections. Words such as \u201cexpects,\u201d \u201cbelieves,\u201d \u201ccan,\u201d \u201cwill,\u201d \u201cestimates,\u201d and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such \u201cforward-looking statements,\u201d which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements may include statements with respect to our projected increase in demand for our thermal weapons displays; our belief that we will gain significant and immediate access to international markets and expanded U.S. defense applications; our belief we can grow aggressively both in the United States and International markets; and our belief that there are opportunities for additional follow-on orders and several new customer development orders which we expect to receive soon. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements, including without limitation our ability to produce thermal weapons displays in adequate quantities to meet projected demand, the outcome of any litigation and other factors beyond our control. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management\u2019s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K, as amended, for the fiscal year ended December 28, 2024, or as updated from time to time our Securities and Exchange Commission filings.<\/p>\n
\n
\n Kopin Corporation<\/b><\/td>\n<\/tr>\n \n Supplemental Information<\/b><\/td>\n<\/tr>\n \n (Unaudited)<\/b><\/td>\n<\/tr>\n \n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n \n Three Months Ended<\/b><\/td>\n \n Nine Months Ended<\/b><\/td>\n<\/tr>\n \n \n September 27, 2025<\/span><\/b><\/td>\n \n September 28, 2024<\/span><\/b><\/td>\n \n September 27, 2025<\/span><\/b><\/td>\n \n September 28, 2024<\/span><\/b><\/td>\n<\/tr>\n \n Display Revenues by Category (in millions)<\/b><\/td>\n \n \n \n \n \n \n <\/tr>\n \n Defense<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n9.9<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n10.4<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n24.6<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n29.1<\/p>\n<\/td>\n<\/tr>\n
\n Industrial\/Enterprise<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n0.8<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n0.5<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2.2<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1.9<\/p>\n<\/td>\n<\/tr>\n
\n Medical<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n–<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n–<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n0.6<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n–<\/p>\n<\/td>\n<\/tr>\n
\n R&D<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1.2<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2.3<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n3.4<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n4.3<\/p>\n<\/td>\n<\/tr>\n
\n License and Royalties<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n0.1<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n0.1<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n0.2<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n0.4<\/p>\n<\/td>\n<\/tr>\n
\n Total<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n12.0<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n13.3<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n31.0<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n35.7<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Stock-Based Compensation Expense<\/b><\/td>\n \n \n \n \n \n \n <\/tr>\n \n Cost of product revenues<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n165,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n368,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n390,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n857,000<\/p>\n<\/td>\n<\/tr>\n
\n Research and development<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n161,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n309,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n403,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n570,000<\/p>\n<\/td>\n<\/tr>\n
\n Selling, general and administrative<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n781,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n536,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,835,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,197,000<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n$<\/p>\n<\/td>\n
\n \n1,107,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n1,213,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n2,628,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n2,624,000<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Other Financial Information<\/b><\/td>\n \n \n \n \n \n \n <\/tr>\n \n Depreciation and amortization<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n194,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n139,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n639,000<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n471,000<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n<\/table>\n \n
\n Kopin Corporation<\/b><\/td>\n<\/tr>\n \n Condensed Consolidated Statements of Operations<\/b><\/td>\n<\/tr>\n \n (Unaudited)<\/b><\/td>\n<\/tr>\n \n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n \n Three Months Ended<\/b><\/td>\n \n Nine Months Ended<\/b><\/td>\n<\/tr>\n \n \n September 27, 2025<\/span><\/b><\/td>\n \n September 28, 2024<\/span><\/b><\/td>\n \n September 27, 2025<\/span><\/b><\/td>\n \n September 28, 2024<\/span><\/b><\/td>\n<\/tr>\n \n Revenues:<\/td>\n \n \n \n \n \n \n <\/tr>\n \n Net product revenues<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n10,693,734<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n10,922,470<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n27,422,055<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n31,001,866<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n Research and development revenues<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,199,937<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,268,072<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n3,344,511<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n4,338,366<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n Other revenues<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n68,754<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n129,066<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n189,234<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n348,440<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n\u00a0<\/p>\n<\/td>\n
\n \n11,962,425<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n13,319,608<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n30,955,800<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n35,688,672<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n Expenses:<\/td>\n \n \n \n \n \n \n <\/tr>\n \n Cost of product revenues<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n8,397,135<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n8,316,904<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n23,098,119<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n25,543,806<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n Research and development<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,502,988<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,596,649<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n6,564,345<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n6,537,065<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n Selling, general and administration<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,629,175<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n5,206,880<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n11,229,549<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n19,706,613<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n Litigation damages<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(5,100,000<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n–<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n(5,100,000<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n24,800,000<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n\u00a0<\/p>\n<\/td>\n
\n \n7,429,298<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n16,120,433<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n35,792,013<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n76,587,484<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Income (Loss) from operations<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n4,533,127<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(2,800,825<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n \n(4,836,213<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(40,898,812<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Other (expense) income, net<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(400,523<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(534,517<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n \n792,651<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(906,743<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Income (Loss) before provision for income taxes<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n4,132,604<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(3,335,342<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n \n(4,043,562<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(41,805,555<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Tax provision<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(52,000<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(125,000<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n \n(156,000<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(125,000<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Net Income (loss)<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n4,080,604<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(3,460,342<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n \n(4,199,562<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n(41,930,555<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Net loss per share:<\/td>\n \n \n \n \n \n \n <\/tr>\n \n Basic<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n0.02<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n(0.03<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n(0.03<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n(0.34<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n<\/tr>\n
\n Diluted<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n0.02<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n(0.03<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n(0.03<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n(0.34<\/p>\n<\/td>\n
\n \n)<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Weighted average number of common shares outstanding:<\/td>\n \n \n \n \n \n \n <\/tr>\n \n Basic<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n166,618,201<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n124,318,056<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n166,362,609<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n121,944,597<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n Diluted<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n169,448,696<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n124,318,056<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n \n166,362,609<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n121,944,597<\/p>\n<\/td>\n
\n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \n \n \n \n \u00a0<\/td>\n<\/tr>\n<\/table>\n \n
\n Kopin Corporation<\/b><\/td>\n<\/tr>\n \n Condensed Consolidated Balance Sheets<\/b><\/td>\n<\/tr>\n \n (Unaudited)<\/b><\/td>\n<\/tr>\n \n \n \n \n \u00a0<\/td>\n<\/tr>\n \n \n September 27, 2025<\/b><\/td>\n \n December 28, 2024<\/b><\/td>\n<\/tr>\n \n ASSETS<\/td>\n \n \n <\/tr>\n \n Current assets:<\/td>\n \n \n <\/tr>\n \n Cash, restricted cash and marketable securities<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n27,558,140<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n36,629,778<\/p>\n<\/td>\n<\/tr>\n
\n Accounts receivable, net<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n6,357,343<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n11,850,654<\/p>\n<\/td>\n<\/tr>\n
\n Inventory<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n6,293,750<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n6,134,096<\/p>\n<\/td>\n<\/tr>\n
\n Contract assets and unbilled receivables<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n10,407,518<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n7,074,020<\/p>\n<\/td>\n<\/tr>\n
\n Prepaid and other current assets<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,558,969<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,153,852<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Total current assets<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n53,175,720<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n62,842,400<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Plant and equipment, net<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,750,197<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,099,708<\/p>\n<\/td>\n<\/tr>\n
\n Operating lease right-of-use assets<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,015,472<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,134,898<\/p>\n<\/td>\n<\/tr>\n
\n Equity investments<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n3,151,255<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n3,564,938<\/p>\n<\/td>\n<\/tr>\n
\n Other assets<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n123,822<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n123,822<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Total assets<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n61,216,466<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n70,765,766<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \u00a0<\/td>\n<\/tr>\n \n LIABILITIES AND STOCKHOLDERS’ EQUITY<\/td>\n \n \n <\/tr>\n \n Current liabilities:<\/td>\n \n \n <\/tr>\n \n Accounts payable<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n6,125,584<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n5,941,470<\/p>\n<\/td>\n<\/tr>\n
\n Accrued expenses<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n3,871,275<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n3,095,414<\/p>\n<\/td>\n<\/tr>\n
\n Accrued Compensation<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n40,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n40,000<\/p>\n<\/td>\n<\/tr>\n
\n Customer deposits<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n9,542<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n–<\/p>\n<\/td>\n<\/tr>\n
\n Deferred tax liabilities<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n465,403<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n414,118<\/p>\n<\/td>\n<\/tr>\n
\n Contract liabilities and billings in excess of revenue earned<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,365,819<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n87,752<\/p>\n<\/td>\n<\/tr>\n
\n Operating lease liabilities<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n775,814<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n639,642<\/p>\n<\/td>\n<\/tr>\n
\n Accrued warranty<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,069,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,557,000<\/p>\n<\/td>\n<\/tr>\n
\n Accrued legal expenses<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,850,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n6,367,900<\/p>\n<\/td>\n<\/tr>\n
\n Accrued litigation damages<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n19,700,000<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n24,800,000<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Total current liabilities<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n36,272,437<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n43,943,296<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Other long term liabilities<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,391,440<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n2,060,932<\/p>\n<\/td>\n<\/tr>\n
\n Operating lease liabilities, net of current portion<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,230,109<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n1,479,976<\/p>\n<\/td>\n<\/tr>\n
\n \n \n \n \u00a0<\/td>\n<\/tr>\n \n Total stockholders’ equity<\/td>\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n21,322,480<\/p>\n<\/td>\n
\n \n \n\u00a0<\/p>\n<\/td>\n
\n \n23,281,562<\/p>\n<\/td>\n<\/tr>\n
\n Total liabilities and stockholders’ equity<\/td>\n \n \n$<\/p>\n<\/td>\n
\n \n61,216,466<\/p>\n<\/td>\n
\n \n \n$<\/p>\n<\/td>\n
\n \n70,765,766<\/p>\n<\/td>\n<\/tr>\n<\/table>\n
\n\u00a0<\/p>\n
<\/p>\n
View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251112869803\/en\/<\/a><\/span><\/p>\n
For Investor Relations
\n<\/b>
Kopin Corporation
\n
Erich Manz
\n<\/b>
Treasurer and Chief Financial Officer
\n
emanz@kopin.com
\n<\/a><\/p>\nMZ Contact
\n<\/b>
Brian M. Prenoveau, CFA
\n
MZ Group \u2013 MZ North America
\n
KOPN@mzgroup.us
\n<\/a>
+561 489 5315<\/p>\nKEYWORDS:<\/b> United States North America Massachusetts<\/p>\n
INDUSTRY KEYWORDS:<\/b> Technology Semiconductor Telecommunications Audio\/Video Internet Hardware Electronic Design Automation Data Management Consumer Electronics<\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20251112869803\/en\/2641407\/3\/KOPN_Logo.jpg\"){kind=logo}
<\/td>\n<\/tr>\n